Immunogenicity and safety of BNT162b2 mRNA vaccine booster in actively treated patients with cancer

被引：32

作者：

Ligumsky, Hagai ^{[1
,6
]}

Dor, Herut ^{[6
]}

Etan, Tal ^{[1
]}

Golomb, Inbal ^{[1
,6
]}

Nikolaevski-Berlin, Alla ^{[1
]}

Greenberg, Inbal ^{[6
]}

Halperin, Tamar ^{[2
]}

Angel, Yoel ^{[3
,6
]}

Henig, Oryan ^{[4
,6
]}

Spitzer, Avishay ^{[1
,6
,7
]}

Slobodkin, Marina ^{[5
,6
]}

Wolf, Ido ^{[1
,6
]}

机构：

[1] Tel Aviv Sourasky Med Ctr, Oncol Div, IL-6423906 Tel Aviv, Israel

[2] Tel Aviv Sourasky Med Ctr, Human Immunodeficiency Virus Lab, IL-6423906 Tel Aviv, Israel

[3] Tel Aviv Sourasky Med Ctr, Dept Anasthesia Pain & Intens Care, IL-6423906 Tel Aviv, Israel

[4] Tel Aviv Sourasky Med Ctr, Dept Infect Dis & Infect Control, IL-6423906 Tel Aviv, Israel

[5] Tel Aviv Sourasky Med Ctr, Dept Internal Med D, IL-6423906 Tel Aviv, Israel

[6] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel

[7] Weizmann Inst Sci, Dept Mol Cell Biol, Rehovot, Israel

来源：

LANCET ONCOLOGY | 2022年 / 23卷 / 02期

关键词：

D O I：

10.1016/S1470-2045(21)00715-4

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：193 / 195

页数：3

共 50 条

[41] Immunogenicity and safety of the BNT162b2 COVID-19 mRNA vaccine in PLWH: A monocentric study in Bari, Italy
Milano, Eugenio
Ricciardi, Aurelia
Casciaro, Raffaella
Pallara, Elisabetta
De Vita, Elda
Bavaro, Davide F.
Larocca, Angela Maria Vittoria
Stefanizzi, Pasquale
Tafuri, Silvio
Saracino, Annalisa
JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (05) : 2230 - 2236
[42] Systems vaccinology of the BNT162b2 mRNA vaccine in humans
Arunachalam, Prabhu S.
Scott, Madeleine K. D.
Hagan, Thomas
Li, Chunfeng
Feng, Yupeng
Wimmers, Florian
Grigoryan, Lilit
Trisal, Meera
Edara, Venkata Viswanadh
Lai, Lilin
Chang, Sarah Esther
Feng, Allan
Dhingra, Shaurya
Shah, Mihir
Lee, Alexandra S.
Chinthrajah, Sharon
Sindher, Sayantani B.
Mallajosyula, Vamsee
Gao, Fei
Sigal, Natalia
Kowli, Sangeeta
Gupta, Sheena
Pellegrini, Kathryn
Tharp, Gregory
Maysel-Auslender, Sofia
Hamilton, Sydney
Aoued, Hadj
Hrusovsky, Kevin
Roskey, Mark
Bosinger, Steven E.
Maecker, Holden T.
Boyd, Scott D.
Davis, Mark M.
Utz, Paul J.
Suthar, Mehul S.
Khatri, Purvesh
Nadeau, Kari C.
Pulendran, Bali
NATURE, 2021, 596 (7872) : 410 - +
[43] Comparative Immunogenicity of BNT162b2 mRNA Vaccine with Natural SARS-CoV-2 Infection
Psichogiou, Mina
Karabinis, Andreas
Poulakou, Garyphallia
Antoniadou, Anastasia
Kotanidou, Anastasia
Degiannis, Dimitrios
Pavlopoulou, Ioanna D.
Chaidaroglou, Antigoni
Roussos, Sotirios
Mastrogianni, Elpida
Eliadi, Irene
Basoulis, Dimitrios
Petsios, Konstantinos
Leontis, Konstantinos
Kakalou, Eleni
Protopapas, Konstantinos
Jahaj, Edison
Pratikaki, Maria
Syrigos, Konstantinos N.
Lagiou, Pagona
Gogas, Helen
Tsiodras, Sotirios
Magiorkinis, Gkikas
Paraskevis, Dimitrios
Sypsa, Vana
Hatzakis, Angelos
VACCINES, 2021, 9 (09)
[44] Immunogenicity Parameters of Cancer Patients Receiving the mRNA Vaccine BNT162b2 While Obtaining Radiotherapy: A Longitudinal Cohort Evaluation
Thoene, Paul
Egger, Margot
Geroldinger-Simic, Marija
Kindermann, Harald
Kocik, Lukas
Karasek, Nicola
Fischerlehner, Barbara
Spiegl, Kurt
Gruber, Georg
Aschacher, Bernhard
Dieplinger, Benjamin
Clodi, Martin
Geinitz, Hans
VACCINES, 2024, 12 (03)
[45] Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in haematopoietic stem cell transplantation recipients
Shem-Tov, Noga
Yerushalmi, Ronit
Danylesko, Ivetta
Litachevsky, Vladislav
Levy, Itzchak
Olmer, Liraz
Lusitg, Yaniv
Avigdor, Abraham
Nagler, Arnon
Shimoni, Avichai
Rahav, Galia
BRITISH JOURNAL OF HAEMATOLOGY, 2022, 196 (04) : 884 - 891
[46] Effectiveness of a Third Dose of BNT162b2 mRNA Vaccine
Saciuk, Yaki
Kertes, Jennifer
Stein, Naama Shamir
Zohar, Anat Ekka
JOURNAL OF INFECTIOUS DISEASES, 2022, 225 (01) : 30 - 33
[47] Efficacy and safety of BNT162b2 mRNA vaccine in a cohort of 90 transfusion dependent thalassemia patients
Marziali, M.
Pugliese, P.
Losardo, A. A.
Ribersani, M.
Anastasi, E.
Angeloni, A.
Pavan, A.
Gentile, G.
TRANSFUSION MEDICINE, 2024, 34 (03) : 238 - 240
[48] The Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Japanese Patients after Allogeneic Stem Cell Transplantation
Watanabe, Marika
Yakushijin, Kimikazu
Funakoshi, Yohei
Ohji, Goh
Hojo, Wataru
Sakai, Hironori
Saeki, Miki
Hirakawa, Yuri
Matsumoto, Sakuya
Sakai, Rina
Nagao, Shigeki
Kitao, Akihito
Miyata, Yoshiharu
Koyama, Taiji
Saito, Yasuyuki
Kawamoto, Shinichiro
Ito, Mitsuhiro
Murayama, Tohru
Matsuoka, Hiroshi
Minami, Hironobu
VACCINES, 2022, 10 (02)
[49] Systems vaccinology of the BNT162b2 mRNA vaccine in humans
Prabhu S. Arunachalam
Madeleine K. D. Scott
Thomas Hagan
Chunfeng Li
Yupeng Feng
Florian Wimmers
Lilit Grigoryan
Meera Trisal
Venkata Viswanadh Edara
Lilin Lai
Sarah Esther Chang
Allan Feng
Shaurya Dhingra
Mihir Shah
Alexandra S. Lee
Sharon Chinthrajah
Sayantani B. Sindher
Vamsee Mallajosyula
Fei Gao
Natalia Sigal
Sangeeta Kowli
Sheena Gupta
Kathryn Pellegrini
Gregory Tharp
Sofia Maysel-Auslender
Sydney Hamilton
Hadj Aoued
Kevin Hrusovsky
Mark Roskey
Steven E. Bosinger
Holden T. Maecker
Scott D. Boyd
Mark M. Davis
Paul J. Utz
Mehul S. Suthar
Purvesh Khatri
Kari C. Nadeau
Bali Pulendran
Nature, 2021, 596 : 410 - 416
[50] Durability of immune responses to the BNT162b2 mRNA vaccine
Suthar, Mehul S.
Arunachalam, Prabhu S.
Hu, Mengyun
Reis, Noah
Trisal, Meera
Raeber, Olivia
Chinthrajah, Sharon
Davis-Gardner, Meredith E.
Manning, Kelly
Mudvari, Prakriti
Boritz, Eli
Godbole, Sucheta
Henry, Amy R.
Douek, Daniel C.
Halfmann, Peter
Kawaoka, Yoshihiro
Boyd, Scott D.
Davis, Mark M.
Zarnitsyna, Veronika I.
Nadeau, Kari
Pulendran, Bali
MED, 2022, 3 (01): : 25 - 27

← 1 2 3 4 5 →